1 Western Sydney University, Penrith, NSW, Australia.
2 Chris O'Brien Lifehouse Comprehensive Cancer Centre, Camperdown, NSW, Australia.
Integr Cancer Ther. 2019 Jan-Dec;18:1534735418823266. doi: 10.1177/1534735418823266.
Interest in integrative oncology (IO) is growing globally. Patients with cancer are actively using traditional complementary and integrative medicine (TCIM) as part of their cancer and survivorship care. Published studies from around the world report increasing use of TCIM by people living with cancer. This article summarizes the presentations that took place during a symposium titled, "Integrative Oncology: International Perspectives" at the International Research Congress on Integrative Medicine and Health in Baltimore, 2018. The purpose of the presentations was to examine whether cancer services across a variety of geographical regions, including Australia, Canada, the United States, and the European Union, were actively responding to cancer survivors' demand for TCIM. The presenters highlighted utilization rates and both facilitators and barriers to the provision of IO services in their respective countries and regions. The audience discussion following the presentations drew out many noteworthy perspectives.
全球范围内对肿瘤整合医学(IO)的兴趣日益浓厚。癌症患者积极使用传统的补充和整合医学(TCIM)作为其癌症治疗和康复护理的一部分。来自世界各地的已发表研究报告显示,癌症患者对 TCIM 的使用呈上升趋势。本文总结了 2018 年在巴尔的摩举行的国际整合医学与健康研究大会上题为“肿瘤整合医学:国际视角”研讨会的演讲内容。演讲的目的是检查包括澳大利亚、加拿大、美国和欧盟在内的各种地理区域的癌症服务是否正在积极响应癌症幸存者对 TCIM 的需求。演讲者强调了他们各自国家和地区提供 IO 服务的利用率以及促进和阻碍因素。演讲后的观众讨论引出了许多值得关注的观点。
Integr Cancer Ther. 2019
BMC Complement Altern Med. 2018-5-9
BMC Complement Altern Med. 2018-10-29
CA Cancer J Clin. 2022-3
J Altern Complement Med. 2021-3
Integr Cancer Ther. 2021
Integr Cancer Ther. 2018-4-2
J Altern Complement Med. 2017-12
J Integr Complement Med. 2025-3
Nutrients. 2024-6-28
Curr Oncol Rep. 2024-4
Healthcare (Basel). 2024-2-4
Cancers (Basel). 2023-12-8
BMC Complement Altern Med. 2018-10-29
Support Care Cancer. 2018-6-3
BMC Complement Altern Med. 2018-5-9
J Natl Cancer Inst Monogr. 2017-11-1
J Natl Cancer Inst Monogr. 2017-11-1